Toward Standardized Methodologies for Drug-Induced Proarrhythmia Classification: An In Silico Proof of Concept.

Area of Science:

• Computational biology
• Pharmacology
• Cardiovascular research

Background:

• Drug-induced proarrhythmic risk assessment faces regulatory limitations with traditional QT interval analysis.
• Computational frameworks are emerging but suffer from methodological variability.
• A standardized in silico approach is needed to improve drug safety prediction.

Purpose of the Study:

• To propose and validate a standardized in silico framework for predicting drug-induced arrhythmic risk.
• To evaluate the impact of electrotonic coupling on risk prediction accuracy.
• To identify key methodological elements for reliable computational drug safety assessment.

Main Methods:

• Generated a virtual population of ventricular cellular models calibrated with patient data.
• Evaluated 10 drugs with varying proarrhythmic risk in isolated-cell and coupled-cell network simulations.
• Developed an arrhythmic risk score integrating 8 electrophysiological biomarkers.

Main Results:

• Electrontically coupled cell models showed comparable predictive performance to isolated-cell models.
• Reducing biomarkers significantly increased false-negative classifications.
• Reduced cellular populations increased the variability of risk score estimation.

Conclusions:

• Electrontically coupled cellular networks offer a physiologically consistent framework for risk prediction.
• Reliable computational assessment necessitates careful consideration of the electrophysiological model, cell population size, and biomarker selection.